ES2039485T3 - Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido. - Google Patents

Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido.

Info

Publication number
ES2039485T3
ES2039485T3 ES198888102557T ES88102557T ES2039485T3 ES 2039485 T3 ES2039485 T3 ES 2039485T3 ES 198888102557 T ES198888102557 T ES 198888102557T ES 88102557 T ES88102557 T ES 88102557T ES 2039485 T3 ES2039485 T3 ES 2039485T3
Authority
ES
Spain
Prior art keywords
substituted
carbon atoms
agents
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888102557T
Other languages
English (en)
Inventor
Hidetsura Cho
Masaru Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2039485T3 publication Critical patent/ES2039485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE 3,4-DIHIDROPIRIMIDINA N-SUSTITUIDOS DE FORMULA (I), EN LA QUE R ES ALQUILO LINEAL, RAMIFICADO, CICLICO O CICLICO-LINEAL QUE TIENE DE UNO A CUATRO ATOMOS DE C, Y X1, X2 Y X3 QUE SON IGUALES O DIFERENTES SON HIDROGENO, HALOGENO, ALQUILO O ALCOXI DE 1 A 4 ATOMOS DEC, NITRO, TRIFLUORMETILO, HIDROXI O TERC-BUTIL-DIMETILSILILOXI, CON LA CONDICION DE QUE NO SEAN LOS TRES HIDROGENO. ESTOS COMPUESTOS TIENEN EFECTOS VASODILATADORES SUSTANCIALMENTE FUERTES Y DURADERO, POR LO QUE SON UTILES COMO AGENTES PARA EL TRATAMIENTO DE DESORDENES DES SISTEMA CARDIOVASCULAR, POR EJEMPLO COMO AGENTES ANTIHIPERTENSORES, MEJORADORES DE LA CIRCULACION Y ANTIANGINOSOS.
ES198888102557T 1987-02-21 1988-02-22 Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido. Expired - Lifetime ES2039485T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62038345A JPS63208580A (ja) 1987-02-21 1987-02-21 Ｎ置換３，４−ジヒドロピリミジン誘導体および循環器系疾患治療剤

Publications (1)

Publication Number Publication Date
ES2039485T3 true ES2039485T3 (es) 1993-10-01

Family

ID=12522695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888102557T Expired - Lifetime ES2039485T3 (es) 1987-02-21 1988-02-22 Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido.

Country Status (6)

Country Link
US (1) US4920124A (es)
EP (1) EP0280227B1 (es)
JP (1) JPS63208580A (es)
AT (1) ATE71620T1 (es)
DE (1) DE3867652D1 (es)
ES (1) ES2039485T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9700209A (et) 1994-11-16 1998-04-15 Synaptic Pharmaceutical Corporation Dihüdropürimidiinid ja nende kasutamine
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
WO2005007124A2 (en) 2003-07-23 2005-01-27 Bristol-Myers Squibb Company Substituted dihydropyrimidine inhibitors of calcium channel function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60214778A (ja) * 1984-03-08 1985-10-28 Suntory Ltd Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
EP0195374B1 (en) * 1985-03-15 1992-07-29 Suntory Limited N-substituted 3,4-dihydropyrimidine derivatives, process for the production thereof and composition containing same for treating disorders of cardiovascular system

Also Published As

Publication number Publication date
EP0280227B1 (en) 1992-01-15
DE3867652D1 (de) 1992-02-27
EP0280227A1 (en) 1988-08-31
JPS63208580A (ja) 1988-08-30
ATE71620T1 (de) 1992-02-15
US4920124A (en) 1990-04-24

Similar Documents

Publication Publication Date Title
UA11100A (uk) Спосіб одержаhhя феhілалкіламіhів або їх фармакологічhо прийhятhих солей
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
ES2039485T3 (es) Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido.
IE860411L (en) N, n - disubstituted aminoacidamides
IN165718B (es)
NO870110L (no) Langkjedede alkylresorcinol-fosfitter.
DK89182A (da) Fremgangsmaade til fremstilling af n-naphthoylglycinderivater
SE8802402D0 (sv) Novel esters
ES2056194T3 (es) Compuestos tetraciclicos antidepresivos.
ES543788A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
ES546366A0 (es) Procedimiento para preparar derivados de 1,6-naftiridina
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
DE3779813D1 (en) 1,4-dihydropyridinderivate.
FI95703C (fi) Fungisidiset 3-imino-1,4-oksatiinit
ATE132038T1 (de) Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
DK0455899T3 (da) Prostaglandin I-analog

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 280227

Country of ref document: ES